Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2010 Oct 12;17(3):330–340. doi: 10.1016/j.bbmt.2010.09.020

Figure 5.

Figure 5

Effect of vaccination site on the survival rate of MMB3.19 myeloid leukemia-challenged mice. B6 mice were vaccinated with a single s.c. or i.p. dose of 2×105 GM-MMB3.19 cells. One week later, mice were exposed to 8.5 Gy and 4 h later transplanted with either B6 syngenic 2×106 ATBM cells alone (ATBM and MMB3.19 groups) or in combination with 4-5×106 lymphocytes (DL, GM-MMB3.19 pre-BMT + DL s.c. and i.p. groups). On day 1 post-BMT, all groups except ATBM controls were challenged with an i.p. injection of 1×105 MMB3.19 cells. Data were pooled from 2-3 separate experiments consisting of 5-10 mice per group.